RECURRENT SOLID TUMOR
Clinical trials for RECURRENT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SOLID TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets Hard-to-Treat tumors in early trial
Disease control Recruiting nowThis study is testing an experimental radioactive drug called 177Lu-SN201 in people with advanced solid tumors that have not responded to standard treatments or for which no standard treatment exists. The drug is designed to deliver radiation directly to tumors. The main goals ar…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated May 26, 2026 03:51 UTC
-
New hope for kids with tough cancers: two drug combos enter trial
Disease control Recruiting nowThis study is for children and young adults (ages 1 to 30) whose solid tumors have come back or never fully went away. It tests two different drug combinations that damage cancer cell DNA to kill the tumor. The goal is to find the safest dose and see if the tumors shrink or disap…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 03:49 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called LY4052031 in people with advanced or spreading solid tumors, including bladder, breast, lung, and other cancers. The goal is to see if the drug is safe and works against these cancers. About 420 participants will take part, and the study will la…
Matched conditions: RECURRENT SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 14, 2026 12:06 UTC